Booz Allen is in a sustained downtrend that has only partially repaired: the stock is down 23.66% over the past year versus a 15.53% gain for the S&P 500, a relative-strength gap of -39.19 percentage points, and it trades at $74.26, which is roughly 31.4% above its 52-week low of $59.50 but still 31.9% below its 52-week high of $109.10 — placing it at about 68% of its 52-week range. That positioning is neither a clean momentum breakout nor a deep-value falling knife; it reflects a damaged long-term trend that has begun to base, with the maximum drawdown of -42.93% underscoring how severe the de-rating has been. Until the stock reclaims the upper half of its range, the path of least resistance remains repair rather than trend continuation.

Short-term momentum is mixed and diverging from the longer-term picture: the stock is up 13.88% over three months (outperforming SPY's 2.69% by 11.19 percentage points) but down 5.29% over the past month while SPY rose 1.22%, a -6.51 point relative-strength gap, and down 12.52% year to date. The three-month rebound off the June low of $59.71 to the September high of $80.06 shows buyers defending the low-60s, but the failure to hold above $80 and the slide back to $74.26 signals decelerating momentum and a likely mean-reversion pause rather than a confirmed reversal. Volume of roughly 1.31 million shares and a short ratio of 4.24 days suggest moderate but not extreme bearish positioning, leaving room for either a squeeze or further distribution.

Key technical levels are well defined: support sits at the $59.50–$60.00 area (the 52-week low and the June/July base), with secondary support near $67–$68 where the October selloff found buyers, while resistance is the $80–$81 zone (the September highs and the April/May congestion) and, above that, the $109.10 52-week high. A decisive break above $81 on volume would signal a trend change and open a retest of the mid-$90s, whereas a breakdown below $67 would put the $59.50 low back in play and likely trigger another leg of de-rating. The stock's beta of 0.368 is unusually low — roughly 63% less volatile than the market — which means position sizing can be larger for a given risk budget, but it also implies the shares will not powerfully lead a broad risk-on rally and that idiosyncratic, contract-driven news will dominate price action.

Revenue is decelerating and, in the latest quarter, contracting: fiscal Q4 2026 revenue of $2.783 billion fell 6.44% year over year from $2.975 billion, following $2.620 billion in Q3 (down from $2.917 billion a year earlier) and $2.890 billion in Q2 (down from $3.146 billion). The multi-quarter trend is clearly negative — three consecutive year-over-year declines — and the mix is dominated by cost-reimbursable contracts at $1.601 billion, with time-and-materials at $632 million and fixed-price at $550 million, meaning margin and revenue are heavily tied to government cost-plus work and contract award timing. The consensus forward revenue estimate of roughly $12.41 billion implies stabilization rather than a return to robust growth, so the investment case now hinges on the Pentagon AI pivot converting into bookings rather than on the legacy consulting base.

Profitability remains solid but is compressing: the latest quarter produced net income of $205 million on a 7.37% net margin, with gross margin of 20.88% and operating margin of 9.75%, down from a 17.44% operating margin in the year-ago Q2 and a 9.99% operating margin in the prior-year Q3. Trailing net margin of 7.59% and gross margin of 20.91% are consistent with a labor-heavy government services model, but the direction is unfavorable — EBITDA fell to $316 million (11.35% margin) from $332 million a year earlier, and interest expense of $48 million against $263 million of operating income leaves interest coverage of about 5.5x. The company is comfortably profitable, but margin expansion will require a richer mix of fixed-price and technology-enabled work.

Balance sheet and cash generation are the strongest part of the story: trailing free cash flow is $951 million, quarterly operating cash flow was $240 million against $28 million of capex, and the company holds $728 million of cash with a current ratio of 1.78. Leverage is the key risk — debt-to-equity of 3.73x, total debt to capitalization of 78.9%, and cash flow to debt of just 0.058 — though interest coverage of 5.5x and a 2.42x dividend-plus-capex coverage ratio show the burden is manageable. ROE of 77.0% is flattered by the leveraged capital structure (equity multiplier of 6.70x) rather than by exceptional returns on assets, which sit at 9.19%; the company funds growth internally and returns cash via a 2.87% dividend yield and buybacks ($77 million repurchased in the latest quarter), but the thin equity base leaves limited cushion if cash flow disappoints.